Rhetoric 174: Rhetoric of Science: Stem Cells and Society

Spring 2007


Location: TuTh 1230-2P, 20 WHEELER

Course Control Number: 77935

Units/Credit: 4

Final Exam Group: 15


Instructor:  Charis M. Thompson

Office: 3412 Dwinelle Hall

510-642 8528

Spring Office Hours:  Friday 10-12 a.m.

charis@berkeley.edu


***Class fulfills requirement for a class in the Ethical, Social, and Legal Implications of Stem Cell Research for CIRM Scholars, California Institute of Regenerative Medicine Training Grant, UC Berkeley***


Requirements:

•Attendance in class (any absences must be excused)

•Active participation in Q&A and small group activities

•On-time delivery of all assignments

•Respect for one another’s opinions

•Willingness to work hard to understand the points of view of others

•Willingness to think about problems from different methodological and disciplinary perspectives


Course Assessment:

Course requirements (attendance, participation, etc)………..……………...25%

Midterm……………………………………………………………………..25%

Final assignment, task 1………………………………………………..……10%

Final assignment, task 2……………………………………………………..10%

Final paper………………………………………………………………..…30%


Reading and Required Books:


All reading is either available online (url’s given in syllabus) or is contained in one of the following four required and two recommended books:


Required: 


1. Scott, Christopher Thomas, 2005.  Stem Cell Now: A Brief Introduction to the Coming Medical Revolution.  Plume.

2. Squier, Susan, 2004.  Liminal Lives: Imagining the Human at the Frontiers of Biomedicine.  Duke University Press.

3. Waldby, Catherine, and Robert Mitchell, 2006.  Tissue Economies: Blood, Organs, and Cell Lines in Late Capitalism.  Duke University Press.

4. Waters, Brent, and Ronald Cole-Turner, eds., 2003.  God and the Embryo: Religious Voices on Stem Cells and Cloning.  Georgetown University Press.


Recommended:

1. Petryna, Adriana, Andrew Lakoff, and Arthur Kleinman, eds., 2006.  Global Pharmaceuticals: Ethics, Markets, and Practices.  Duke University Press

2. Thompson, Charis, 2005.  Making Parents: The Ontological Choreography of Reproductive Technologies.  MIT Press.


Structure of Classes:


1. Stem Cell Science in Society Then, Now, and Next 

1a) Science and Modernity

1b) Framings

1c) Media and Popular Culture


2. Ethics and Values

2a) Procurement

2b) Informed Consent

2c) Justice


3. Law, Politics, Governance, and Economics 

3a) Legalities

3b) Markets

3c) Governance



Schedule of Classes:

 

Stem Cell Science in Society Then, Now, and Next


Tuesday January 9, 2007: From ELSI to ELSPETH: introductory lecture on approach and scope of the class, how you will be evaluated and what you will know at the end of it.


Reading: Stem Cells Now – this text should be used for understanding of the issues; read as you deem appropriate throughout the semester.


1a) History


Thursday January 11: Science and Democracy from Eugenics to the Aftermath of WWII and the Cold War

 

Reading: i)  HYPERLINK "http://www.nsf.gov/about/history/vbush1945.htm" http://www.nsf.gov/about/history/vbush1945.htm 

Bush, Vannevar, 1945. Science The Endless Frontier

ii)  HYPERLINK "http://www.nature.com/nature/journal/v402/n6761supp/full/402c81a0_fs.html" http://www.nature.com/nature/journal/v402/n6761supp/full/402c81a0_fs.html Gibbons, Michael, 1999.  “Science’s New Social Contract with Society,” Nature 402:C81


Tuesday January 16: The Roles of the Academy / Industry / Government / Military / Public / Private in Funding and Directing Translational, “Bench to Bedside” Biomedicine 


Reading: i)  HYPERLINK "http://www.sciencemag.org/cgi/content/full/300/5617/286" http://www.sciencemag.org/cgi/content/full/300/5617/286

Collins, Francis S., Michael Morgan, Aristides Patrinos, 2003: “The Human Genome Project: Lessons from Large-Scale Biology,” Science Vol. 300, 5617: 286 – 290 

ii)  HYPERLINK "http://www.cirm.ca.gov/" http://www.cirm.ca.gov/ 

Proposition 71: The California Stem Cell Research and Cures Act


Thursday January 18: History of Stem Cell Research: From Nuclear Medicine to (E)nucleated Medicine


Reading: i) J. E. Till, E. A. McCulloch, and L. Siminovitch, 1964. “A Stochastic Model of Stem Cell Proliferation, Based on the Growth of Spleen Colony-Forming Cells,” Proc Natl Acad Sci, January; 51(1): 29–36;

ii) Martin, G.R.,1981. “Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells,” Proc. Nat. Acad. Sci.: 78, 7634–7638.

iii) Evans, M., and Kaufman, M.H.,1981. “Establishment in culture of pluripotential cells from mouse embryos,” Nature 292, 154–155;

iv) Wilmut, Ian, A. E. Schnieke, J. McWhir, A. J. Kind & K. H. S. Campbell, 1997.  “Viable offspring derived from fetal and adult mammalian cells,” Nature 385, 810 - 813 

v) Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and Jones, J.M.,1998. Embryonic stem cell lines derived from human blastocysts,” Science 282, 1145–1147.


1b) Framings


Tuesday January 23: Who Supports and Who Opposes (which kinds of) Stem Cell Research and Why?  


Reading: i)  HYPERLINK "http://www.godandscience.org/doctrine/stemcell.html" http://www.godandscience.org/doctrine/stemcell.html   

“Arguments Against Proposition 71: The California Stem Cell Research and Cures Initiative,” 

ii)  HYPERLINK "http://www.curesforcalifornia.com/" http://www.curesforcalifornia.com/ 

 “Curing Diseases and Saving Lives”


Thursday January 25: Lines in the Sand: Human Futures and Inheritable Genetic Modification; Rejuvenation and Reanimation


Reading: i) “The Hybrid Embryo and Xenogenic Desire,” and “Incubabies and Rejuvenates: The Traffic Between Technologies of Reproduction and Age Extension,” in Liminal Lives, pp. 89-111 and146-167

ii) HYPERLINK "http://nobelprize.org/nobel_prizes/chemistry/articles/berg/index.html" http://nobelprize.org/nobel_prizes/chemistry/articles/berg/index.html

Berg, Paul, 2004.  “Asilomar and Recombinant DNA,”


Tuesday January 30:  In the Shadow of Abortion Politics: “Leftover” Embryos, Therapeutic / Research Cloning (SCNT) and Reproductive Cloning


Reading: i)  HYPERLINK "http://www.nightlight.org/snowflakeadoption.htm" http://www.nightlight.org/snowflakeadoption.htm

“Nightlight Adoptions Snowflakes Program.”

ii)  HYPERLINK "http://www.ornl.gov/sci/techresources/Human_Genome/elsi/cloning.shtml" http://www.ornl.gov/sci/techresources/Human_Genome/elsi/cloning.shtml  

"Cloning Fact Sheet."


1c) Media and Popular Culture

 

Thursday February 1: Public Understanding of Science: Stem Cell Hype and Hope in the Media and the Role of Education


Reading: i)  HYPERLINK "http://www.cirm.ca.gov/strat/" http://www.cirm.ca.gov/strat/

“CIRM Draft Scientific Strategic Plan, October 2006.”

ii)  HYPERLINK "http://news.bbc.co.uk/1/hi/sci/tech/4213566.stm" http://news.bbc.co.uk/1/hi/sci/tech/4213566.stm

“Winston Warns of Stem Cell Hype.”


Tuesday February 6: Regenerative Medicine in Fiction and Film


Watch: Dirty Pretty Things (2002) Directed by Stephen Frears, on reserve, Media Library

Reading: “Transplant Medicine and Transformative Narrative,” and “The Pluripotent Discourse of Stem Cells,” Liminal Lives, pp.  168-213 and 253-280


2) Ethics


Thursday February 8: Guest lecture:  California Institute for Regenerative Medicine Ethics and Accountability, Geoff Lomax, PhD., CIRM Senior Officer for Medical and Ethical Standards


Reading: TBA


2a) Procurement


Tuesday February 13: The Moral Status of the Embryo and Beyond.  Guest Lecture on Christian Perspectives on Human Embryonic Stem Cell Research, Nancy Duff, Professor of Christian Ethics, Princeton Theological Seminary


Reading: “Religion Meets Research,” and “What is the Appropriate Contribution of Religious Communities in the Public Debate on Embryonic Stem Cell Research,” pp. 7-28, and browse through “Appendices,” pp. 163- 221, God and the Embryo.


Thursday February 15: Trafficking in Persons?: Procuring Embryos, Gametes, or Tissue from Cadaver, Biopsy, or Fetuses for Stem Cell Research


Reading: i) “Introduction: Gifts, Commodities, and Human Tissues,” “Disentangling the Embryonic Gift,” pp. 1-34 and 59-82, Tissue Economies.

ii)  HYPERLINK "http://www.asrm.org" http://www.asrm.org

Ethics Committee of the American Society for Reproductive Medicine, 2004.  “Disposition of Abandoned Embryos,” Fertility and Sterility 82:1: S253

 iii) “The Sacred and Profane Human Embryo: A biomedical Mode of (Re)Production?” pp. 245-276, Making Parents.


Tuesday February 20: Women’s Health, Feminism, and Egg Donation: Procurement, Provenance, Payment, Participation


Reading:  i)  HYPERLINK "http://www.asrm.org/Media/Press/policyeggdonation.htmlPolicy" http://www.asrm.org/Media/Press/policyeggdonation.htmlPolicy  

Part II: Egg Donation: Cost of Implementing FDA Regulations; Influence of Donor Compensation in Recruitment; Donor Agencies’ Compliance with ASRM Guidelines, October 24, 2006.”

ii)  HYPERLINK "http://www.genetics-and-society.org/resources/background/eggextraction.html" http://www.genetics-and-society.org/resources/background/eggextraction.html

“Egg Extraction For Stem Cell Research: Issues for Women’s Health.”

iii)  HYPERLINK "http://www.iom.edu/CMS/3740/36353/36363/36365.aspx" http://www.iom.edu/CMS/3740/36353/36363/36365.aspx 

“IOM Agenda. Public Workshop on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research., September 2006” (view agenda topics).

iv) Thompson, Charis, 2007. “Why We Should Pay Egg Donors,” forthcoming in Regenerative Medicine.


Thursday February 22: Alternative Sources of Pluripotent Stem Cells 


Reading: i)  HYPERLINK "http://bioethics.gov/reports/white_paper/text.html" http://bioethics.gov/reports/white_paper/text.html 

“Alternative Sources of Pluripotent Stem Cells,” President’s Council on Bioethics

ii) Klimanskaya, Irina, Young Chung, Sandy Becker, Shi-Jiang Lu, and Robert Lanza, 2006.Human embryonic stem cell lines derived from single blastomeres,” Nature, advance online publication 23 August 2006.

ii) Turnpennya, Lee, Sarah Brickwooda, Cosma M. Spallutoa, Karen Pipera, Iain T. Cameronb, David I. Wilsona, Neil A. Hanleya, 2003.  “Derivation of Human Embryonic Germ Cells: An Alternative Source of Pluripotent Stem Cells,” Stem Cells 21:598-609

iii) Blelloch, Robert, Zhongde Wanga, Alex Meissnera, Steven Pollard, Austin Smith, Rudolf Jaenisch, 2006. “Reprogramming Efficiency Following Somatic Cell Nuclear Transfer Is Influenced by the Differentiation and Methylation State of the Donor Nucleus,” Stem Cells 24, 9: 2007-2013.

iv) Cowan, Chad, Jocelyn Atienza, Douglas A. Melton, Kevin Eggan, 2005. “Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic,” Stem Cells 309, 5739: 1369–1373.

v) Taranger, Christel K., Agate Noer, Anita L. Sørensen, Anne-Mari Håkelien, Andrew C. Boquest, and Philippe Collas, 2005.  “Induction of Dedifferentiation, Genomewide Transcriptional Programming, and Epigenetic Reprogramming by Extracts of Carcinoma and Embryonic Stem Cells,” MBC Vol. 16, Issue 12, 5719-5735


Tuesday February 27: Pre-Implantation Genetic Diagnosis for Adult and Embryonic Stem Cell Extraction / Derivation: Savior Siblings, Designer Babies, Diseases in a Dish


Reading: i)  HYPERLINK "http://www.bmj.com/cgi/content/full/323/7323/1240" http://www.bmj.com/cgi/content/full/323/7323/1240

Boyle, Robert, and Julian Savulescu, 2001. “Ethics of using preimplantation genetic diagnosis to select a stem cell donor for an existing person,” BMJ 2001;323:1240-1243

ii) de Wert, Guido, 2005.  Preimplantation genetic diagnosis: the ethics of intermediate cases,” Human Reproduction 2005 20(12):3261-3266


2b) Informed Consent


Thursday March 1: History of Biomedical Ethics: The Principles


Reading:  HYPERLINK "http://ohsr.od.nih.gov/guidelines/guidelines.html" http://ohsr.od.nih.gov/guidelines/guidelines.html  

“The Belmont Report,” “Nuremberg Code,” and “World Medical Association Declaration of Helsinki.”


Tuesday March 6: Clinical Trials and Informed Consent for Stem Cell Therapies


Reading: i)  HYPERLINK "http://www.clinicaltrials.gov/ct/info/resources" http://www.clinicaltrials.gov/ct/info/resources

“An Introduction to Clinical Trials,” and “Participation in Clinical Trials.”

ii)  HYPERLINK "http://www.npr.org/templates/story/story.php?storyId=6394957" http://www.npr.org/templates/story/story.php?storyId=6394957

“Stem Cell Inc.’s Neural Stem Cell Clinical Trial for Batten’s Disease.”

iii) “Globalizing Human Subjects Research,” pp. 33-60, Global Pharmaceuticals.


Thursday March 8: Chimeras and Animal Rights


Reading: i)  HYPERLINK "http://www.pbs.org/newshour/science/chimeras/qanda.html" http://www.pbs.org/newshour/science/chimeras/qanda.html

“What are Chimeras and Why are they Created?”

ii)  HYPERLINK "http://www.iacuc.org/" http://www.iacuc.org/ 

iii)  HYPERLINK "http://www.sciencemag.org/cgi/content/full/308/5728/1538" http://www.sciencemag.org/cgi/content/full/308/5728/1538

Gunjan Sinha, 2005.  “Human Embryonic Stem Cells May Be Toxicology's New Best Friends,”  Science Vol. 308. no. 5728, p. 1538

iv)  HYPERLINK "http://phgu.org.uk/ecard.php?link_ID=2798" http://phgu.org.uk/ecard.php?link_ID=2798 

Brice, Philippa, 2006.  “Human-cow chimeric embryos for stem cell research,” PHGU Newsletter, 7 November 2006


Tuesday March 13: Research Ethics / Integrity: Why/ how did Hwang-gate happen and how do we stop it from happening again?


Reading: i)  HYPERLINK "http://www.universityofcalifornia.edu/compliance/ethics/" http://www.universityofcalifornia.edu/compliance/ethics/ 

UC Ethics Website

ii)  HYPERLINK "http://www.sciencemag.org/sciext/hwang2005/" http://www.sciencemag.org/sciext/hwang2005/

Hwang Scandal

iii)  HYPERLINK "http://www.nature.com/news/2005/051219/full/051219-3.html" http://www.nature.com/news/2005/051219/full/051219-3.html

“Timeline of a Controversy.”


2c) Justice


Thursday March 15: Distributive Justice: access and affordability, education and market opportunity, risk and benefit, research and health priorities


Reading: HYPERLINK "http://medicine.plosjournals.org/perlserv?request=get-document&doi=10.1371/journal.pmed.0030126" http://medicine.plosjournals.org/perlserv?request=getdocument&doi=10.1371/journal.pmed.0030126

Goozner, Merrill, 2006.  “Innovation in Biomedicine: Can Stem Cell Research Lead the Way to Affordability?” PLoS Med 3(5): e126


Tuesday March 20: Diversity in California’s Stem Cell Initiative


Reading:  HYPERLINK "http://www.greenlining.org/program/research.php" http://www.greenlining.org/program/research.php “Toward Fair Cures: Diversity Policies in Stem Cell Research,” “Toward Fair Cures: Issues in the Medical Research Process,” and “Economic Development and Stem Cell Research.”


Thursday March 22: Disability Rights and Patient Stem Cell Advocacy: Health Social Movements and Medical and Social Models of Disease 


Watch:  HYPERLINK "http://www.youtube.com/watch?v=a9WB_PXjTBo" www.youtube.com/watch?v=a9WB_PXjTBo

“Michael J. Fox on Stem Cells.”

 HYPERLINK "http://www.youtube.com/watch?v=rkA1aN1osVk" www.youtube.com/watch?v=rkA1aN1osVk

Michael J. Fox (with Parkinsons) talks Stem Cell Research.”

Reading:  HYPERLINK "http://www.leeds.ac.uk/disability-studies/archiveuk/Crow/exploring%20the%20divide%20ch4.pdf" www.leeds.ac.uk/disability-studies/archiveuk/Crow/exploring%20the%20divide%20ch4.pdf

Crow, Liz, 1996.  “Including All Of Our Lives: Renewing The Social Model Of

Disability,” in Colin Barnes and Geof Mercer, eds., Exploring the Divide, Leeds: The Disability Press, pp. 55 – 72.


—————Spring Break: March 26-March 30—————


Tuesday April 3: In-class midterm: short answers, must answer four of six questions


No reading: prepare for exam based on lectures and reading


Thursday April 5: Guest lecture: Christopher Thomas Scott, Stanford University, Director, Stem Cells and Society


Reading:  Stem Cell Now - finish


Introduction of final project requirements


3) The Law, Politics, Governance, Business, and Economics:


3a) Legalities


Tuesday April 10: Bayh-Dole, the Spur to Innovation, Intellectual Property Rights, and Material Transfer Agreements


Reading:   HYPERLINK "http://www.ucop.edu/ott/faculty/bayh.html" http://www.ucop.edu/ott/faculty/bayh.html  

“The Bayh-Dole Act: A Guide To The Law And Implementing Regulations.”


Part 1 of final paper due in: name of interview contact, or film/book archive, and 5 item bibliography, at least three of which must be drawn from class readings


Thursday April 12: IP in local, national, and international contexts and its commercial implications.  Guest lecture: Kenneth Taymor on CIRM IP Policies in context of national and international IP, and commercialization prospects


Reading: TBA


Tuesday April 17: Regenerative Medicine and Privacy Guest Lecture, Deirdre Mulligan, Law and Technology Center, UC Berkeley. 


Reading:  HYPERLINK "http://aspe.hhs.gov/admnsimp/pl104191.htm" http://aspe.hhs.gov/admnsimp/pl104191.htm

“Health Insurance Portability And Accountability Act Of 1996.”


3b) Markets


Thursday April 19: Will Stem Cell Research in California Make, Save, or Cost Money?

 

Reading:  HYPERLINK "http://region.princeton.edu/media/pub/pub_xtra_19.pdf" http://region.princeton.edu/media/pub/pub_xtra_19.pdf  

Noll, Roger, 2005.  “The Politics and Economics of Implementing State-Sponsored Embryonic Stem Cell Research.”


Tuesday April 24: R&D Concerns: Scaling Stem Cell Based Therapies; Bridging Animal Models to Clinical Trials; Promise of in vitro Stem Cell Research


Reading: i)  HYPERLINK "http://www.ansci.wisc.edu/facstaff/Faculty/pages/cezar/pubs.htm" http://www.ansci.wisc.edu/facstaff/Faculty/pages/cezar/pubs.htm  

“New Stem Cell Safety Sciences laboratory,” Wisconsin Association for Biomedical Research and Education. (Biosciences Wisconsin 2006)

ii)  HYPERLINK "http://www.genengnews.com/articles/chitem.aspx?aid=1806&chid=3" http://www.genengnews.com/articles/chitem.aspx?aid=1806&chid=3 

Liszewski, Kathy, 2006.  “Biomanufacturing for Regenerative Medicine Tissue Engineering and Cell-based Therapies Go Beyond the Therapeutic Reach of a Pill,” Genetic Engineering News Jun 15 2006 (Vol. 26, No. 12)


3c) Governance


Thursday April 26: Biobanking: Guest lecture, Professor David Winickoff, UC Berkeley


Reading: Winickoff, 2006.  “Bioethics and Stem Cell Banking in California,” Berkeley Technology Law Journal 21:3, 1067-1106


Tuesday May 1: Stem Cell Policy and Regulation in the US: NIH, National Academies of Science, State Laws 


Reading: i)  HYPERLINK "http://www.nap.edu/openbook/0309096537/html/index.html" http://www.nap.edu/openbook/0309096537/html/index.html

“Guidelines for Human Embryonic Stem Cell Research” 

ii)  HYPERLINK "http://stemcells.nih.gov/policy/" http://stemcells.nih.gov/policy/

“Federal Policy.”

iii)  HYPERLINK "http://www.ncsl.org/programs/health/Genetics/embfet.htm" http://www.ncsl.org/programs/health/Genetics/embfet.htm

“State Embryonic and Fetal Research Laws”


Part 2: transcript or extensive notes on interview, or text/film analysis due in


Thursday May 3: Stem Cell Research Around the World: Religion, Culture, Regulation


Reading: Available through  HYPERLINK "http://www.ingentaconnect.com/content" http://www.ingentaconnect.com/content 

Isasi R., and Knoppers B.M., 2006. “Mind the Gap: Policy Approaches to Embryonic Stem Cell and Cloning Research in 50 Countries,” Volume 13, Number 1, 2006, pp. 9-25(17)


Tuesday May 8: Wrap Up lecture / Q&A

Reading:


Final Paper due Friday May 11, drop off at my office by noon.